Abstract
We here introduce a novel bioreducible polymer-based gene delivery platform enabling widespread transgene expression in multiple brain regions with therapeutic relevance following intracranial convection-enhanced delivery. Our bioreducible nanoparticles provide markedly enhanced gene delivery efficacy in vitro and in vivo compared to nonbiodegradable nanoparticles primarily due to the ability to release gene payloads preferentially inside cells. Remarkably, our platform exhibits competitive gene delivery efficacy in a neuron-rich brain region compared to a viral vector under previous and current clinical investigations with demonstrated positive outcomes. Thus, our platform may serve as an attractive alternative for the intracranial gene therapy of neurological disorders.
Original language | English (US) |
---|---|
Pages (from-to) | 4567-4572 |
Number of pages | 6 |
Journal | ACS Biomaterials Science and Engineering |
Volume | 9 |
Issue number | 8 |
DOIs | |
State | Published - Aug 14 2023 |
Keywords
- bioreducible polymer
- brain extracellular matrix
- brain gene therapy
- intracranial administration
- polymeric nanoparticle.
ASJC Scopus subject areas
- Biomedical Engineering
- Biomaterials